Achieving strong growth

During the year, progress against our strategic objectives included:

1

Increasing Genetic Control and Product Differentiation

  • Successfully launching Sexcel – our proprietary bovine sexed genetics product – globally, supported by processing facilities in the US and India
  • Significantly strengthening our dairy bull line up through De Novo produced genetics
  • Introducing Icon Sires, to give customers early access to elite dairy genetics, in return for the option to buy progeny at a pre-set price and breeding rights to any bulls
  • Continuing to evolve NuEra Genetics, our proprietary beef range, by introducing NuEra bulls to our US beef-on-dairy offer and achieving top rankings in BeefAdvantage, EMEA’s beef-on-dairy index
2

Targeting Key Markets and Segments

  • Harnessing Sexcel to strengthen relationships with dairy farmers across EMEA
  • Enhancing our focus on large dairy accounts, particularly in the US, with whom we partner on both genetic improvement strategy and operational activities
  • Increasing sales of embryos by 20%, as we continue to engage larger customers with the benefits embryos offer as a genetic improvement platform
  • Expanding our range of economic indices for beef, introducing the proprietary XBlack index in Brazil to identify the most profitable genetics for crossbreeding in tropical conditions
3

Sharing in the Value Delivered

  • Exploring a transition to performance-based pricing, based on helping progressive dairy farmers achieve their genetic improvement goals
  • Using our growing range of indices to align pricing of the most profitable genetics with the value they deliver
arrow